论文部分内容阅读
目的异丙托溴铵与布地奈德雾化吸入治疗慢性阻塞性肺疾病急性加重期(AECOPD)的疗效观察。方法 88例AECOPD患者随机分为观察组和对照组,各44人,两组均在常规治疗的基础上加用雾化吸入,观察组异丙托溴铵加布地奈德雾化吸入,对比两组效果。结果观察组与对照组的对比差异有显著性意义(P<0.01),观察组的疗效优于对照组。结论异丙托溴铵与布地奈德雾化吸入对辅助治疗AECOPD有协同作用。
Objective To observe the curative effect of ipratropium bromide and budesonide inhalation on acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods 88 patients with AECOPD were randomly divided into observation group and control group, 44 in each group. Both groups were treated with nebulized inhalation on the basis of routine treatment. The patients in the observation group received inhalation of ipratropium bromide and budesonide, Group effect. Results The difference between the observation group and the control group was significant (P <0.01), and the observation group was superior to the control group. Conclusions Ipratropium bromide and budesonide inhalation have a synergistic effect on the adjuvant treatment of AECOPD.